Europe in the vaccine race: "Machine to lose"

The European Union had a historic opportunity to prove its irreplaceable usefulness to its citizens.

Faced with the universal peril of the pandemic, it was going to show the strength of its unity by collectively negotiating the purchase, at the best price and time, of 2.3 billion doses of anti-Covid vaccine.

What would not have been said if the Twenty-Seven had engaged in a rat race to monopolize more precious serums than the neighbor?

No: we would soon celebrate the same photo taken simultaneously of the first vaccinated in each country.

This promise of power and harmony was too tempting for the capitals to refuse to transfer to the Brussels Commission a prerogative it does not have.

But that was counting without the losing machine that the European bureaucracy seems to have irremediably become.

Cumbersome, incompetence, aversion to risk: the juggernaut, to whose wishes pharmaceutical companies had to comply, goes after almost everyone - United States, United Kingdom,

This article is for subscribers only.

You have 52% left to discover.

Subscribe: 1 € the first month

Cancellable at any time

I ENJOY IT

Already subscribed?

Log in